Scholarlink

<p>We present an integrated system that combines dynamic optical coherence tomography (DOCT) with a small cell-cultivation chamber to enable high-sensitivity and high-temporal-resolution imaging of tumor spheroid’s drug response. Unlike conventional OCT-based volume measurement, which only captures late-stage morphological changes, our system captures early-stage changes in spheroid’s intracellular activity. The compact chamber, positioned beneath the DOCT probe, maintains a cell-culture environment (37 <InlineEquation ID="IEq1"> <EquationSource Format="TEX">\(^\circ\)</EquationSource> </InlineEquation>C, 5% CO<InlineEquation ID="IEq2"> <EquationSource Format="TEX">\(_2\)</EquationSource> </InlineEquation>) while allowing frequent system access without disturbing the cultivation environment. The proposed system was used to monitor human breast cancer (MCF-7) spheroids response to doxorubicin hydrochloride, tamoxifen citrate, and paclitaxel over 100 hours at 4-hour intervals. While standard OCT-based volume measurement failed to detect early-stage drug concentration impacts, DOCT signals revealed statistically significant differences among the drug concentrations as early as 12 hours. Additionally, high-temporal-resolution imaging at 30-minute intervals over 100 hours revealed rapid and subtle changes in the spheroid morphology and DOCT signals. The results demonstrate that the proposed integrated system of DOCT and cultivation chamber provides a superior, early-readout platform for label-free anti-cancer drug testing compared to traditional structural OCT imaging.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Dynamic optical coherence microscope integrated with cell-cultivation chamber enabled longitudinal and early-stage assessment of tumor spheroid-drug interaction

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年3月19日

查看全文
  • Ibrahim Abd El-Sadek,
  • Rion Morishita,
  • Yu Guo,
  • Atsuko Furukawa,
  • Pradipta Mukherjee,
  • Shuichi Makita,
  • Masahiro Miura,
  • Satoshi Matsusaka,
  • Yoshiaki Yasuno

摘要

We present an integrated system that combines dynamic optical coherence tomography (DOCT) with a small cell-cultivation chamber to enable high-sensitivity and high-temporal-resolution imaging of tumor spheroid’s drug response. Unlike conventional OCT-based volume measurement, which only captures late-stage morphological changes, our system captures early-stage changes in spheroid’s intracellular activity. The compact chamber, positioned beneath the DOCT probe, maintains a cell-culture environment (37 \(^\circ\) C, 5% CO \(_2\) ) while allowing frequent system access without disturbing the cultivation environment. The proposed system was used to monitor human breast cancer (MCF-7) spheroids response to doxorubicin hydrochloride, tamoxifen citrate, and paclitaxel over 100 hours at 4-hour intervals. While standard OCT-based volume measurement failed to detect early-stage drug concentration impacts, DOCT signals revealed statistically significant differences among the drug concentrations as early as 12 hours. Additionally, high-temporal-resolution imaging at 30-minute intervals over 100 hours revealed rapid and subtle changes in the spheroid morphology and DOCT signals. The results demonstrate that the proposed integrated system of DOCT and cultivation chamber provides a superior, early-readout platform for label-free anti-cancer drug testing compared to traditional structural OCT imaging.